Unrivalled throughput
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run, while current technologies are limited to 384 single cells, and enable the detection of single-cell level CNV events via shallow sequencing. The Shasta Total RNA-Seq Kit is the first high-throughput single-cell total RNA profiling kit to offer full gene body coverage of up to 100,000 cells per run. It is capable of detecting RNA biotypes, such as non-polyadenylated lncRNAs, otherwise missed by current droplet-based technologies. This represents a significant advancement over traditional plate-based full-length RNA-seq and high-throughput mRNA-seq methods.
“We have entered a new era in single-cell analysis, where Shasta technologies overcome previous limitations enabling detection of critical events such as splicing isoforms, gene fusions, lncRNAs, and segmental CNVs. By enabling true biomarker discovery at scale, we are providing researchers with the confidence and capability to achieve insights that were previously out of reach,” said Matthieu Pesant, PhD, Senior Market Strategy Manager for Translational Genomics at Takara Bio Europe.
Takara Bio Europe will showcase the Shasta Single-Cell System at the 2024 Human Cell Atlas General Meeting, taking place from September 29 - October 1, 2024. We invite all attendees to visit us at Booth #5 and attend Technology Showcase Session 2 on September 30 at 12:55 pm, presented by Matthieu Pesant, PhD, Senior Market Strategy Manager for Translational Genomics at Takara Bio Europe.
“I’m thrilled to share how Shasta Single-Cell System is set to revolutionise single-cell omics. Stop by our booth or join my talk to see first-hand how this technology can transform your research by detecting critical genetic events with unmatched throughput and sensitivity,” said Dr. Pesant.
About Takara Bio
Takara Bio Europe is a leading manufacturer and supplier of molecular and cellular research reagents and services. With over 25 years of experience, our high-quality, innovative tools help to accelerate translational and clinical discoveries.
Key products include SMART cDNA synthesis kits for a variety of samples and applications, including NGS, high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes), Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins.
Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit www.takarabio.com.
Takara Bio Inc., a world leader in biotechnology research and development, offers a host of life science research solutions, from enzymes and GMP-grade reagents to contracted cell and gene therapy manufacturing services and is the developer of the RetroNectin® reagent, a world standard in gene therapy protocols. Takara Bio is committed to preventing disease and improving the quality of life for all people through the use of biotechnology.